Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
ROCZ ended development of PDE-4 inhibitors, MEM 1917 and MEM1414. MEM 1917 was in preclinical development to treat AD and depression, and MEM1414 was in Phase I testing for AD. Under a 2002 deal, ROCZ...
